Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 03 Feb 2026 08:00 CET |
ZELLUNA | Zelluna promotes Emilie Gauthy to Chief Technology Officer | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Feb 2026 08:00 CET |
ZELLUNA | Zelluna utnevner Emilie Gauthy til Chief Technology Officer | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 15 Jan 2026 12:22 CET |
ZELLUNA | Zelluna ASA: Approval and publication of prospectus | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Dec 2025 17:26 CET |
ZELLUNA | Zelluna har nådd en viktig milepæl og innleverer søknad om klinisk studie i Storbritannia for første studie på mennesker av ZI-MA4-1 (ZIMA-101), verdens første MAGE-A4-rettede TCR-NK celleterapi for solide kreftformer. | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 17 Dec 2025 17:26 CET |
ZELLUNA | Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World's First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2025 12:36 CET |
ZELLUNA | Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World's First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Dec 2025 13:02 CET |
ZELLUNA | Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2025 09:36 CET |
ZELLUNA | Zelluna ASA: Cancellation of subsequent repair offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2025 08:22 CET |
ZELLUNA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Dec 2025 18:36 CET |
ZELLUNA | Zelluna ASA - Mandatory notification of trade | 20103010 Biotechnology | Major shareholding notifications |
| 08 Dec 2025 13:52 CET |
ZELLUNA | Zelluna ASA: New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2025 07:50 CET |
ZELLUNA | Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Nov 2025 08:35 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 25 Nov 2025 16:05 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 25 Nov 2025 12:09 CET |
ZELLUNA | ZELLUNA ASA: DISCLOSURE OF LARGE SHAREHOLDING | 20103010 Biotechnology | Major shareholding notifications |
| 25 Nov 2025 11:32 CET |
ZELLUNA | Zelluna ASA - Extraordinary General Meeting held on November 25, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Nov 2025 10:33 CET |
ZELLUNA | Zelluna ASA: New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 13:04 CET |
ZELLUNA | Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 09:10 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 08:28 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 07:29 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 07:00 CET |
ZELLUNA | Zelluna ASA - Ex. date | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 00:58 CET |
ZELLUNA | Zelluna ASA - Key information relating to subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 00:35 CET |
ZELLUNA | Zelluna ASA - Mandatory notification of trade | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 23:52 CET |
ZELLUNA | Zelluna ASA - Successful private placement and retail offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 16:47 CET |
ZELLUNA | Zelluna ASA - Contemplates private placement | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 16:39 CET |
ZELLUNA | Zelluna ASA Reports Third Quarter 2025 Financial Results and Provides General Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Oct 2025 07:58 CEST |
ZELLUNA | Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK | 20103010 Biotechnology | Inside information |
| 10 Sep 2025 08:00 CEST |
ZELLUNA | Zelluna Announces Investor Forum on Science & Strategy to be held on Wednesday 17 September 2025 | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Aug 2025 07:00 CEST |
ZELLUNA | Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 14 Aug 2025 12:00 CEST |
ZELLUNA | Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Jul 2025 12:07 CEST |
ZELLUNA | Zelluna ASA - Grant of Share Options under Long-Term Incentive Program | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Jun 2025 16:19 CEST |
ZELLUNA | Disclosure of share transfer from Inven2 AS | 20103010 Biotechnology | Non-regulatory press releases |
| 27 May 2025 13:51 CEST |
ZELLUNA | Disclosure of Shareholding - Gjelsten Holding AS | 20103010 Biotechnology | Major shareholding notifications |
| 27 May 2025 13:38 CEST |
ZELLUNA | ZLNA - New registered share capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 May 2025 08:37 CEST |
ZELLUNA | ZLNA - Issuance of shares through set-off of option exercise fee | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 May 2025 07:00 CEST |
ZELLUNA | Zelluna ASA Reports First Quarter 2025 Financial Results and Provides General Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2025 08:00 CEST |
ZELLUNA | Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Apr 2025 14:50 CEST |
ZELLUNA | Zelluna ASA - Annual General Meeting held on April 29, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Apr 2025 07:47 CEST |
ZELLUNA | Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours | 20103010 Biotechnology | Inside information |
| 08 Apr 2025 08:43 CEST |
ZELLUNA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Apr 2025 15:21 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 04 Apr 2025 07:00 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Notice of Annual General Meeting on April 29, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Apr 2025 07:00 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Annual Report 2024 | 20103010 Biotechnology | Annual financial and audit Reports |
| 01 Apr 2025 08:00 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Ex reverse share split today | 20103010 Biotechnology | Ex Date |
| 31 Mar 2025 17:16 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Registration of reverse share split | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Mar 2025 15:27 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Key information regarding reverse share split and change of ISIN | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Mar 2025 10:21 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Share capital increase registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Mar 2025 13:55 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 26 Mar 2025 13:22 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Share capital increase resolution | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |